• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Model Number 142122-02
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Restenosis (4576)
Event Date 10/03/2022
Event Type  Injury  
Event Description
The patient was treated as part of the mimics 3d usa post-market observational study.On the (b)(6) 2021, the patient was implanted with one biomimics 3d (bm3d) stent, a 6.0 x 60mm stent which was used to treat a denovo lesion of the superficial femoral artery (sfa) proximal third in the left leg.A contralateral approach was used and the lesion was prepared using pre-dilation with percutaneous transluminal angioplasty (pta) balloon and atherectomy.The treated segment was also post-dilated with pta.The site reported that on (b)(6) 2022, an event of limb ischemia was identified.It was reported as not related to the device and not related to the procedure but due to a worsening pre-existing condition.A severe in-stent stenosis was also identified.It was reviewed by veryan's chief medical officer on (b)(6) 2023, this was considered to be possibly related to the device.The limb ischemia was treated with a surgical graft bypass and endarterectomy of the sfa proximal third and distal popliteal artery on 06-oct-22.It was reported as a target vessel revascularisation (tvr).The patient outcome was reported as resolved with sequelae and the device remains implanted.
 
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of restenosis leading to intervention and limb ischemia are listed in the biomimics 3d instructions for use and are known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
unit 11 galway technology park
parkmore road
galway, H91 V E0H
EI  H91 VE0H
Manufacturer Contact
alan mcdonagh
unit 11 galway technology park
parkmore road
galway, H91 V-E0H
EI   H91 VE0H
MDR Report Key16947229
MDR Text Key315407144
Report Number3011632150-2023-00066
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850398
UDI-Public(01)05391526850398(17)220715(11)201214(10)0000063196
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/15/2022
Device Model Number142122-02
Device Catalogue Number142122-02
Device Lot Number0000063196
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/19/2023
Initial Date FDA Received05/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/14/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.; CLOPIDOGREL (PLAVIX).
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexMale
Patient Weight98 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-